Brodimoprim
Jump to navigation
Jump to search
| File:Brodimoprim.svg | |
| Gene therapy | |
|---|---|
| Clinical data | |
| ATC code | |
| Physiological data | |
| Legal status | |
| Pharmacokinetic data | |
| Identifiers | |
| |
| PubChem Template:Abbreviation | |
| Chemical and physical data | |
| Formula | C13H15BrN4O2 |
| Molar mass | 339.188 g/mol |
Brodimoprim is a structural derivative of trimethoprim. In brodimoprim, the 4-methoxy group of trimethoprim is replaced with a bromine atom.
As trimethoprim, brodimoprim is a selective inhibitor of bacterial dihydrofolate reductase.[1]
References
Template:Pharmacology-stub Template:Sulfonamides and trimethoprim
Categories:
- Articles with short description
- Pages with broken file links
- Infobox-drug molecular-weight unexpected-character
- Chemical articles without CAS registry number
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Dihydrofolate reductase inhibitors